Provider
P38-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Program effective Date: Apr 01, 2019
Documents & Forms Results
Displaying 2931 - 2940 of 3629 results
Provider
P33-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business
Program effective Date: Apr 01, 2019
Provider
P35-19 Appeals Policy for no Prior Authorization Effective June 3, 2019
Program effective Date: Apr 01, 2019
Provider
QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Program effective Date: Mar 27, 2019
Provider
QP33-19 SmartChoice Program for Fully Insured Commercial Products
Program effective Date: Mar 27, 2019
Provider
QP32-19 Pharmacy Benefit Exclusion for Glyrx-PF, Libtayo, Lumoxiti, Onpattro, Poteligeo, and Xerava
Program effective Date: Mar 27, 2019
Provider
QP34-19 Pharmacy Benefit Exclusion for Antineoplastic and Adjunctive Therapies
Program effective Date: Mar 27, 2019
Provider
QP31-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Program effective Date: Mar 27, 2019
Provider
QP29-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Arikayce
Program effective Date: Mar 27, 2019
Provider
QP23-19 Reminder Payment Policy Auditing System
Program effective Date: Mar 13, 2019